Authors
Loading...
Proteomic study identifies stage-specific molecular signatures in non-invasive bladder cancer, suggesting potential prognostic biomarkers.
Vantaggiato et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: